VC005 placebo tablets

DRUG2 trials

Sponsors

Jiangsu vcare pharmaceutical technology co., LTD

Conditions

Alopecia AreataInflammatory Bowel Diseases

Phase 1

Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects

CompletedNCT05354752

Jiangsu vcare pharmaceutical technology co., LTDInflammatory Bowel Diseases

Start: 2022-06-18End: 2022-11-15Updated: 2022-11-17

Phase 2

Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata

RecruitingNCT07749716

Jiangsu vcare pharmaceutical technology co., LTDAlopecia Areata

Start: 2026-08-18End: 2028-12-30Target: 120Updated: 2026-08-27